Note: Ingredients listed on restricted chemical lists
EC/CAS
200-015-4/50-18-0
Name of the chemical
Cyclophosphamide (INN) and its salts
Concentration
N/A
General Information
Version
4
Revision date
2025-06-16
Product name
Cyclophosphamide Powder for Injection
Product name
Cyclophosphamide Powder for Injection
Identification on the label/Trade name
CYCLOPHOSPHAMIDE Alkylating Agent
Chemical name
Alkylating Agent
CAS No.
50-18-0
1.2.1 Relevant identified uses
Pharmaceutical product used as Antineoplastic
Emergency telephone
1-800-424-9300, +1-703-527-3887
Icons in SDS
Company Information
company name
Pfizer Inc
e-mail address of the competent person responsible for the Safety Data Sheet
pfizer-MSDS@pfizer.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H301, H340, H350, H360FD, H362, H372
Hazard statements
Code
Statements
H301
Toxic if swallowed
Section 2
SECTION 2: Hazards identification
OSHA Classification of the substance or mixture
2.3 Other hazards
Not applicable (HNOC) An Occupational Exposure Value has been established for this substance ( see Section 8 ).
Signal word
Danger
Hazard statements
H301 - Toxic if swallowed H350 - May cause cancer H340 - May cause genetic defects H360FD - May damage fertility. May damage the unborn child H362 - May cause harm to breast-fed children H372 - Causes damage to organs through prolonged or repeated exposure
Precautionary statements
P201 - Obtain special instructions before use P202 - Do not handle until all safety precautions have been read and understood P264 - Wash hands thoroughly after handling P270 - Do not eat, drink or smoke when using this product P281 - Use personal protective equipment as required P308 + P313 - IF exposed or concerned: Get medical advice/attention P263 - Avoid contact during pregnancy/while nursing P405 - Store locked up P501 - Dispose of contents/container in accordance with local, regional, national, and international regulations as applicable
PBT Substances
& vPvB The product does not contain any substance(s) classified as PBT or vPvB. Endocrine Disruptor Information This product does not contain any known or suspected endocrine disruptors. Note This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the product or its ingredients regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.
2.1 Classification of the substance or mixture
GHS - Classification: Regulated according to Regulation (EC) 1272/2008 and/or other applicable regulations. Acute toxicity - Oral Category 3 - (H301) Germ cell mutagenicity Category 1B - (H340) Carcinogenicity Category 1A - (H350) Reproductive toxicity Category 1A - (H360FD) Effects on or via lactation Yes - (H362) Specific target organ toxicity (repeated exposure) Category 1 - (H372) OSHA Classification Hazards not otherwise classified (HNOC) Not applicable Hazards classified under paragraph (d)(1)(ii) of 1910.1200 Not applicable
